Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension
about
My approach to the treatment of sclerodermaSurvival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertensionRaynaud's phenomenon, inflammatory arthritis, and weight loss: pay attention to the man behind the curtain.Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectases.Lung involvement in systemic sclerosis.A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosisAntinuclear antibody-negative systemic sclerosis.Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.Systemic sclerosis--challenges for clinical practice.Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.Review: evidence that systemic sclerosis is a vascular disease.Pulmonary hypertension in connective tissue diseases: an update.Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease.The miR-146a rs2910164 C/G polymorphism is associated with telangiectasia in systemic sclerosis.Gastrointestinal and Hepatic Disease in Systemic Sclerosis.Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis
P2860
Q24618843-FE24DF54-549D-4731-B6BC-170247C3ABA2Q33759804-427627A5-AEA2-412F-A167-43639CF1E13FQ34128485-5394A153-8421-4BAC-80BA-2BA5AEF818E2Q34249495-E442BD8C-F8F0-4B58-9CAA-B2154DFAE876Q34732817-CBFACC54-0563-430A-AE30-D7B2660ADFC3Q35096375-285A4E47-DB8B-4D08-887C-9CFF7662FF17Q35661256-256BB746-F876-4DE4-807E-0A29A0EB081EQ36146293-38093F1D-6E34-4A8D-83E6-236FE364C72EQ37224668-9D9BED19-CEC1-4324-A277-FB4D5D9A2C40Q37413166-62C8C67D-906D-4FEF-B674-7F1B6B51CF41Q37686449-D5A4E940-21C4-4B12-978F-AFA410CCFA12Q37955130-D5A308D4-AC03-41EC-B49F-D9B63E604946Q38059459-9A58A809-1D91-4374-811A-F29C134F8A7EQ38071978-CD10122F-8DBC-466F-9BB9-0293373BEE55Q38105984-A0E6CB90-BDE6-44E4-9054-F2D133E754DAQ39138240-277030BD-2E43-4D97-87A0-2E4C40539F40Q40079788-1B703E06-BAB7-4D8A-8FD1-ED4ED0440738Q40322755-DA291102-2ACB-4739-B2CB-DF8D926C1687Q44232564-64F75E15-D7AB-4DE9-B4B6-59ED50DDF76DQ47705348-E59A8302-C494-43E0-A07C-6C86E6AB2908Q56977476-B91AB115-267E-41AF-949A-652C19A7182F
P2860
Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Telangiectases in scleroderma: ...... ulmonary arterial hypertension
@ast
Telangiectases in scleroderma: ...... ulmonary arterial hypertension
@en
type
label
Telangiectases in scleroderma: ...... ulmonary arterial hypertension
@ast
Telangiectases in scleroderma: ...... ulmonary arterial hypertension
@en
prefLabel
Telangiectases in scleroderma: ...... ulmonary arterial hypertension
@ast
Telangiectases in scleroderma: ...... ulmonary arterial hypertension
@en
P2093
P2860
P356
P1476
Telangiectases in scleroderma: ...... ulmonary arterial hypertension
@en
P2093
Ami A Shah
Fredrick M Wigley
Laura K Hummers
P2860
P304
P356
10.3899/JRHEUM.090697
P407
P577
2009-12-01T00:00:00Z